Field Fluid Heating Device Helps Prevent Hypothermia
By HospiMedica International staff writers Posted on 10 Sep 2014 |
A portable fluid warming device warms intravenous (IV) fluids prior to administration in both clinical and field environments.
The HypothermX HX100 device is designed to warm IV fluids, blood, or blood products infused into a patient via sterile fluid paths with the intent to treat traumatic, environmental, procedure related and/or induced hypothermia. The heating is accomplished via a flameless hydrocarbon combustion process fueled with an isobutane/propane mixture, thereby eliminating the need for external power to operate. The device can also work in a closed-loop heating mode, whereby the patient’s own blood is extracted, heated, and re-infused.
The light weight device offers therapeutic warming in the field for injured patients for up to four hours, and is capable of warming up to five liters of saline introduced at 15 °C and 15 units of packed red blood cells introduced at 5 °C to 38 °C, with an infusion rate of between 50–200 mL/min in ambient conditions of 0–40 °C. The system has numerous safety features, including the ability to temporarily silence alarms based on operational needs. The HypothermX IV and blood warming device is a product EMIT Corporation (Houston, TX, USA), and has received the European Community CE marking of approval.
“The documented improvement in clinical outcomes with first responder administration of blood, plasma, and blood products at the point of injury, as quickly as possible, is enabled with our product,” said Jeffery Sheldon, Chairman and CEO of EMIT. “The product's ease of use and ability to warm sufficient resuscitative fluid volume over unmatched timeframes makes it ideal for military, air medical transport, mobile, remote, austere, and power challenged environments.”
Related Links:
EMIT Corporation
The HypothermX HX100 device is designed to warm IV fluids, blood, or blood products infused into a patient via sterile fluid paths with the intent to treat traumatic, environmental, procedure related and/or induced hypothermia. The heating is accomplished via a flameless hydrocarbon combustion process fueled with an isobutane/propane mixture, thereby eliminating the need for external power to operate. The device can also work in a closed-loop heating mode, whereby the patient’s own blood is extracted, heated, and re-infused.
The light weight device offers therapeutic warming in the field for injured patients for up to four hours, and is capable of warming up to five liters of saline introduced at 15 °C and 15 units of packed red blood cells introduced at 5 °C to 38 °C, with an infusion rate of between 50–200 mL/min in ambient conditions of 0–40 °C. The system has numerous safety features, including the ability to temporarily silence alarms based on operational needs. The HypothermX IV and blood warming device is a product EMIT Corporation (Houston, TX, USA), and has received the European Community CE marking of approval.
“The documented improvement in clinical outcomes with first responder administration of blood, plasma, and blood products at the point of injury, as quickly as possible, is enabled with our product,” said Jeffery Sheldon, Chairman and CEO of EMIT. “The product's ease of use and ability to warm sufficient resuscitative fluid volume over unmatched timeframes makes it ideal for military, air medical transport, mobile, remote, austere, and power challenged environments.”
Related Links:
EMIT Corporation
Read the full article by registering today, it's FREE!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
- Free digital version edition of HospiMedica International sent by email on regular basis
- Free print version of HospiMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of HospiMedica International in digital format
- Free HospiMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest Critical Care News
- Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients
- Peptide-Based Hydrogels Repair Damaged Organs and Tissues On-The-Spot
- One-Hour Endoscopic Procedure Could Eliminate Need for Insulin for Type 2 Diabetes
- AI Can Prioritize Emergency Department Patients Requiring Urgent Treatment
- AI to Improve Diagnosis of Atrial Fibrillation
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure